| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.001 | 0.97 | Diuretic | 0.884 0.002 CID_154699545 0.894 0.002 CID_91810647 | ||
| 0.964 | 0 | 0.964 | Aldosterone antagonist | 0.801 0.001 CID_154699545 0.822 0 CID_91810647 | ||
| 0.878 | 0.004 | 0.878 | Cardiotonic | 0.857 0.004 CID_154699545 0.845 0.004 CID_91810647 | ||
| 0.843 | 0.001 | 0.843 | Mineralocorticoid receptor antagonist | 0.802 0.001 CID_154699545 0.78 0.001 CID_91810647 | ||
| 0.842 | 0.012 | 0.879 | Apoptosis agonist | 0.806 0.016 CID_154699545 0.879 0.008 CID_91810647 | CID_91810647 | |
| 0.778 | 0.014 | 0.845 | Transcription factor NF kappa B inhibitor | 0.821 0.011 CID_154699545 0.845 0.01 CID_91810647 | CID_91810647 | |
| 0.732 | 0.025 | 0.732 | Antiinflammatory | 0.711 0.029 CID_154699545 0.713 0.028 CID_91810647 | ||
| 0.653 | 0.002 | 0.653 | Lipocortins synthesis antagonist | 0.62 0.002 CID_154699545 0.632 0.002 CID_91810647 | ||
| 0.597 | 0.01 | 0.643 | Nitric oxide antagonist | 0.643 0.008 CID_154699545 0.576 0.011 CID_91810647 | CID_154699545 | |
| 0.551 | 0.02 | 0.551 | Immunosuppressant | 0.551 0.02 CID_154699545 0.524 0.027 CID_91810647 | ||
| 0.502 | 0.02 | 0.547 | Caspase 3 stimulant | 0.426 0.037 CID_154699545 0.547 0.014 CID_91810647 | CID_91810647 | |
| 0.469 | 0.004 | 0.469 | Hedgehog signaling inhibitor | 0.277 0.005 CID_154699545 0.227 0.008 CID_91810647 | ||
| 0.448 | 0.005 | 0.448 | Interleukin 6 antagonist | 0.43 0.006 CID_154699545 0.375 0.009 CID_91810647 | ||
| 0.442 | 0.004 | 0.442 | Aromatase inhibitor | 0.349 0.004 CID_154699545 0.254 0.006 CID_91810647 | ||
| 0.417 | 0.013 | 0.426 | Sodium/bile acid cotransporter inhibitor | 0.426 0.011 CID_154699545 0.421 0.012 CID_91810647 | CID_154699545 | |
| 0.418 | 0.014 | 0.492 | P-glycoprotein inhibitor | 0.492 0.009 CID_154699545 0.319 0.026 CID_91810647 | CID_154699545 | |
| 0.428 | 0.024 | 0.428 | Hypoxia-inducible factor 1 alpha inhibitor | 0.37 0.039 CID_154699545 0.403 0.029 CID_91810647 | ||
| 0.398 | 0.002 | 0.398 | Glucocorticoid antagonist | 0.286 0.003 CID_154699545 0.324 0.002 CID_91810647 | ||
| 0.401 | 0.005 | 0.401 | Androgen antagonist | 0.258 0.009 CID_154699545 0.371 0.005 CID_91810647 | ||
| 0.321 | 0.017 | 0.339 | Interferon gamma antagonist | 0.339 0.015 CID_154699545 0.281 0.023 CID_91810647 | CID_154699545 | |
| 0.26 | 0.004 | 0.26 | Progesterone antagonist | 0.118 0.008 CID_154699545 0.094 0.009 CID_91810647 | ||
| 0.248 | 0.006 | 0.261 | Arachidonic acid antagonist | 0.255 0.005 CID_154699545 0.261 0.004 CID_91810647 | CID_91810647 | |
| 0.295 | 0.055 | 0.295 | Tumour necrosis factor alpha release inhibitor | 0.173 0.132 CID_154699545 0.189 0.119 CID_91810647 | ||
| 0.308 | 0.08 | 0.345 | Apoptosis antagonist | 0.345 0.058 CID_154699545 0.271 0.108 CID_91810647 | CID_154699545 | |
| 0.308 | 0.086 | 0.319 | Cholesterol antagonist | 0.319 0.079 CID_154699545 0.295 0.094 CID_91810647 | CID_154699545 | |
| 0.234 | 0.02 | 0.249 | Cholesterol synthesis inhibitor | 0.249 0.018 CID_154699545 0.175 0.034 CID_91810647 | CID_154699545 | |
| 0.218 | 0.009 | 0.218 | Antineoplastic alkaloid | 0.203 0.013 CID_154699545 0.19 0.017 CID_91810647 | ||
| 0.232 | 0.032 | 0.272 | Melanin inhibitor | 0.272 0.025 CID_154699545 0.192 0.045 CID_91810647 | CID_154699545 | |
| 0.203 | 0.005 | 0.203 | 5-Alpha-reductase inhibitor | 0.121 0.008 CID_154699545 0.099 0.01 CID_91810647 | ||
| 0.213 | 0.019 | 0.25 | Antineoplastic antibiotic | 0.219 0.018 CID_154699545 0.25 0.014 CID_91810647 | CID_91810647 | |
| 0.246 | 0.06 | 0.246 | Psychostimulant | 0.137 0.129 CID_154699545 0.159 0.108 CID_91810647 | ||
| 0.21 | 0.025 | 0.21 | DNA polymerase I inhibitor | 0.208 0.026 CID_154699545 0.175 0.037 CID_91810647 | ||
| 0.187 | 0.005 | 0.187 | Opioid kappa receptor agonist | 0.178 0.005 CID_154699545 0.161 0.005 CID_91810647 | ||
| 0.174 | 0.006 | 0.174 | Androgen agonist | 0.146 0.008 CID_154699545 0.149 0.007 CID_91810647 | ||
| 0.183 | 0.015 | 0.183 | Estrogen antagonist | 0.138 0.029 CID_154699545 0.176 0.016 CID_91810647 | ||
| 0.214 | 0.057 | 0.218 | Hepatoprotectant | 0.199 0.065 CID_154699545 0.218 0.055 CID_91810647 | CID_91810647 | |
| 0.158 | 0.004 | 0.158 | 5-Alpha-reductase 1 inhibitor | 0.051 0.007 CID_154699545 0.051 0.007 CID_91810647 | ||
| 0.157 | 0.005 | 0.164 | Na+ K+ transporting ATPase inhibitor | 0.164 0.004 CID_154699545 0.15 0.006 CID_91810647 | CID_154699545 | |
| 0.153 | 0.004 | 0.153 | RNA-directed RNA polymerase stimulant | 0.124 0.005 CID_154699545 0.133 0.004 CID_91810647 | ||
| 0.174 | 0.027 | 0.232 | Microtubule formation inhibitor | 0.232 0.013 CID_154699545 0.196 0.021 CID_91810647 | CID_154699545 | |
| 0.152 | 0.006 | 0.152 | Estradiol 17 beta-dehydrogenase inhibitor | 0.146 0.006 CID_154699545 0.085 0.012 CID_91810647 | ||
| 0.159 | 0.014 | 0.162 | Anabolic | 0.155 0.016 CID_154699545 0.162 0.012 CID_91810647 | CID_91810647 | |
| 0.143 | 0.003 | 0.143 | Progesterone agonist | 0.096 0.004 CID_154699545 0.081 0.004 CID_91810647 | ||
| 0.207 | 0.07 | 0.207 | Neurotrophic factor enhancer | 0.203 0.073 CID_154699545 0.181 0.097 CID_91810647 | ||
| 0.288 | 0.168 | 0.288 | Calcium channel L-type activator | 0.288 0.168 CID_154699545 0.271 0.184 CID_91810647 | ||
| 0.244 | 0.126 | 0.279 | Interleukin 2 agonist | 0.229 0.144 CID_154699545 0.279 0.09 CID_91810647 | CID_91810647 | |
| 0.12 | 0.004 | 0.12 | 5-Alpha-reductase 2 inhibitor | 0.059 0.007 CID_154699545 0.029 0.009 CID_91810647 | ||
| 0.135 | 0.028 | 0.135 | Interleukin 2 antagonist | 0.122 0.042 CID_154699545 | ||
| 0.12 | 0.014 | 0.12 | Estrogen agonist | 0.088 0.02 CID_154699545 0.111 0.015 CID_91810647 | ||
| 0.115 | 0.01 | 0.115 | Estrogen receptor beta agonist | 0.089 0.013 CID_154699545 0.102 0.011 CID_91810647 | ||
| 0.126 | 0.022 | 0.126 | Opioid kappa receptor antagonist | 0.111 0.027 CID_154699545 0.104 0.031 CID_91810647 | ||
| 0.117 | 0.02 | 0.134 | Glycine receptor antagonist | 0.121 0.018 CID_154699545 0.134 0.012 CID_91810647 | CID_91810647 | |
| 0.102 | 0.005 | 0.102 | Lipocortins synthesis agonist | 0.093 0.007 CID_154699545 0.102 0.005 CID_91810647 | ||
| 0.228 | 0.146 | 0.228 | Antithrombotic | 0.206 0.17 CID_154699545 | ||
| 0.116 | 0.037 | 0.12 | Estrogen receptor beta antagonist | 0.105 0.055 CID_154699545 0.12 0.032 CID_91810647 | CID_91810647 | |
| 0.192 | 0.12 | 0.318 | Antioxidant | 0.211 0.106 CID_154699545 0.318 0.056 CID_91810647 | CID_91810647 | |
| 0.098 | 0.028 | 0.098 | Estrogen receptor alpha antagonist | 0.076 0.054 CID_154699545 0.091 0.034 CID_91810647 | ||
| 0.19 | 0.124 | 0.19 | DNA damaging | |||
| 0.071 | 0.006 | 0.071 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.063 0.007 CID_154699545 0.037 0.018 CID_91810647 | ||
| 0.074 | 0.021 | 0.074 | Heme oxygenase stimulant | 0.073 0.021 CID_154699545 0.072 0.022 CID_91810647 | ||
| 0.133 | 0.081 | 0.186 | Protein kinase stimulant | 0.186 0.047 CID_154699545 0.163 0.06 CID_91810647 | CID_154699545 | |
| 0.129 | 0.084 | 0.136 | Farnesoid X receptor antagonist | 0.136 0.072 CID_91810647 | CID_91810647 | |
| 0.135 | 0.091 | 0.135 | NOS3 expression enhancer | 0.121 0.113 CID_154699545 0.13 0.097 CID_91810647 | ||
| 0.058 | 0.017 | 0.061 | Microtubule stabilization | 0.061 0.013 CID_154699545 0.06 0.014 CID_91810647 | CID_154699545 | |
| 0.049 | 0.008 | 0.049 | Estrone sulfatase inhibitor | 0.033 0.01 CID_154699545 0.025 0.013 CID_91810647 | ||
| 0.251 | 0.212 | 0.297 | Cyclophilin D inhibitor | 0.297 0.165 CID_91810647 | CID_91810647 | |
| 0.047 | 0.013 | 0.048 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.015 CID_154699545 0.048 0.013 CID_91810647 | CID_91810647 | |
| 0.101 | 0.068 | 0.109 | Toll-Like receptor 4 antagonist | 0.099 0.072 CID_154699545 0.109 0.057 CID_91810647 | CID_91810647 | |
| 0.037 | 0.004 | 0.037 | Corticosteroid-like | 0.03 0.006 CID_154699545 0.037 0.004 CID_91810647 | ||
| 0.05 | 0.017 | 0.055 | Estrogen receptor alpha agonist | 0.034 0.024 CID_154699545 0.055 0.016 CID_91810647 | CID_91810647 | |
| 0.04 | 0.009 | 0.04 | Elastase 2B inhibitor | 0.035 0.013 CID_91810647 | ||
| 0.04 | 0.009 | 0.04 | Elastase 3B inhibitor | 0.035 0.013 CID_91810647 | ||
| 0.04 | 0.009 | 0.04 | Elastase 3A inhibitor | 0.035 0.013 CID_91810647 | ||
| 0.06 | 0.03 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 CID_154699545 0.053 0.037 CID_91810647 | CID_154699545 | |
| 0.041 | 0.014 | 0.047 | Tubulin agonist | 0.047 0.01 CID_154699545 0.034 0.024 CID_91810647 | CID_154699545 | |
| 0.261 | 0.24 | 0.261 | Caspase 9 stimulant | 0.252 0.251 CID_154699545 | ||
| 0.025 | 0.007 | 0.025 | Glucocorticoid agonist | 0.011 0.01 CID_154699545 0.025 0.007 CID_91810647 | ||
| 0.02 | 0.003 | 0.02 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.003 CID_154699545 0.017 0.004 CID_91810647 | ||
| 0.054 | 0.037 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.039 CID_154699545 0.056 0.034 CID_91810647 | CID_91810647 | |
| 0.052 | 0.038 | 0.057 | Opioid agonist | 0.057 0.033 CID_154699545 | CID_154699545 | |
| 0.14 | 0.125 | 0.159 | Anesthetic general | 0.137 0.129 CID_154699545 0.159 0.104 CID_91810647 | CID_91810647 | |
| 0.136 | 0.129 | 0.136 | Interleukin antagonist | |||
| 0.03 | 0.029 | 0.03 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.075 | 0.077 | 0.083 | Opioid antagonist | 0.083 0.065 CID_154699545 | CID_154699545 | |
| 0.155 | 0.194 | 0.214 | DNA synthesis inhibitor | 0.214 0.103 CID_91810647 | CID_91810647 | |
| 0.052 | 0.114 | 0.071 | Glycine receptor agonist | 0.071 0.052 CID_91810647 | CID_91810647 | |
| 0.184 | 0.25 | 0.331 | Antibacterial | 0.331 0.114 CID_154699545 0.288 0.144 CID_91810647 | CID_154699545 | |
| 0.009 | 0.32 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_154699545 | CID_154699545 | |
| 0.044 | 0.414 | 0.156 | Platelet adhesion inhibitor | 0.156 0.1 CID_91810647 | CID_91810647 | |
| 0.004 | 0.565 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 CID_154699545 | CID_154699545 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |